HDSN
HUDSON TECHNOLOGIES INC /NY
NASDAQ · Basic Materials · Chemicals - Specialty · US
$4.44
+2.66%Year over year
Reported trailing growth
- Revenue
- +2.3%
- EBITDA
- -81.4%
- EBIT
- -96.6%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +2.3%
- EBITDA
- +196.5%
- EPS
- +1102.1%
Three-year CAGR
- Revenue
- -8.8%
- EBITDA
- -40.7%
- EBIT
- -47.9%
- Net income
- -45.6%
- EPS
- -45.2%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026